Skip to main content


Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study

Fig. 2

OR (95% CI) for each 10 μg/ml (approximately 1 SD) increase in baseline RBP4 levels for the novel development of metabolic syndrome (MS) in subjects not effected at baseline or the persistence of MS among subjects with MS at baseline and at 10-year follow-up. ORs were adjusted for age, gender, pubertal stage, waist circumference, systolic blood pressure, HDL-C, fasting blood glucose, and TG levels at baseline

Back to article page